Abnormal eye movements in parkinsonism: a historical view

Area of Science:

• Neurology
• Ophthalmology
• Movement Disorders

Background:

• Parkinson's disease (PD), historically known as paralysis agitans, was first described by James Parkinson in 1817.
• Charcot and his students later named the disease and defined its variants, with Arthur Dutil noting abnormal eye movements.
• Despite advancements, the differential diagnosis of PD remains primarily clinical, impacting prognosis, treatment, and research.

Purpose of the Study:

• To highlight the growing importance of the eye movement examination in the context of Parkinson's disease.
• To emphasize its utility in the differential diagnosis of parkinsonism.
• To explore its potential role in identifying genetic PD subtypes and early cognitive decline.

Main Methods:

• Review of historical and contemporary literature on Parkinson's disease and eye movement abnormalities.
• Analysis of the diagnostic relevance of clinical eye movement assessments in parkinsonism.
• Exploration of the link between eye movements, genetic PD, and cognitive function.

Main Results:

• The eye movement examination has evolved as a critical tool in understanding and diagnosing Parkinson's disease.
• It proves effective for differentiating parkinsonism and supporting the diagnosis of PD.
• Potential applications include identifying genetic forms of PD and aiding in the early detection of cognitive impairment.

Conclusions:

• The eye movement examination is an increasingly valuable component of Parkinson's disease assessment.
• Its application extends to differential diagnosis, genetic subtyping, and early cognitive decline recognition.
• Further research into eye movement analysis may enhance PD management and understanding.